Tailored insights, in real-time, from your global clinical experts.
Recently, the FDA approved fam-trastuzumab deruxtecan-nxki (T-DXd), which is marketed as Enhertu, for two new indications in HER2-postive, early-stage breast cancer in adults1: Clinical trial
There are a variety of biologics approved to treat autoimmune diseases, such as psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn’s. Until now, the standard of
Pharmaceutical companies operate in one of the most competitive and fast-moving industries in the world. With mounting pressures to bring therapies to market faster and
Earlier this year, the FDA approved a new targeted chemotherapy, Datroway (datopotamab deruxtecan) for adults with unresectable or metastatic hormone receptor (HR)-positive, HER2 negative breast
Recently, the FDA approved pembrolizumab for adults with resectable locally advanced head and neck squamous cell carcinoma (HNSCC). The treatment is approved as a neoadjuvant